Last news
Evome Medical Technologies Posts Third Quarter 2024 Results, Generates $424,000 in Adjusted EBITDA on Stable Revenues, Further Reduces Debt
Published: 2024-11-25 12:36:07
Neptune Strengthens Bitcoin Treasury with Ongoing DCA Strategy Using Rewards and Strategic Derivative Trades
Published: 2024-11-25 12:36:06
Corning offers to waive exclusive deals in EU antitrust probe, may stave off fine
Published: 2024-11-25 12:36:05
Cognition Therapeutics' Analysis Correlates Biomarker Changes with Cognitive Benefit in Alzheimer's Population
Published: 2024-11-25 12:32:19
Palatin Announces Completion of Patient Enrollment in Phase 2 Study of Orally Administered Melanocortin Agonist PL8177 in Ulcerative Colitis
Published: 2024-11-25 12:32:18
Plus Therapeutics Presents Positive ReSPECT-LM Phase 1 Interim Data for Leptomeningeal Metastases at the 2024 SNO Annual Conference
Published: 2024-11-25 12:32:14
Rakovina Therapeutics Presents AI-Driven Drug Discovery Research at Society for Neuro-Oncology Annual Meeting
Published: 2024-11-25 12:32:14
